Arantza Vega

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms

Iván Álvarez‐Twöse, David González‐de‐Olano, Laura Sánchez‐Muñoz et al. · Journal of Allergy and Clinical Immunology · 2010 · 291 citations

Life Sciences, Cell Biology, Immunology +16

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM

Iván Álvarez‐Twöse, Roberta Zanotti, David González‐de‐Olano et al. · Journal of Allergy and Clinical Immunology · 2013 · 140 citations

Life Sciences, Dermatology, Immunology +16

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis

David González‐de‐Olano, Iván Álvarez‐Twöse, M. I. Esteban‐López et al. · Journal of Allergy and Clinical Immunology · 2008 · 129 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Venom Immunotherapy in Patients with Clonal Mast Cell Disorders: Efficacy, Safety, and Practical Considerations

Patrizia Bonadonna, David González‐de‐Olano, Roberta Zanotti et al. · The Journal of Allergy and Clinical Immunology In Practice · 2013 · 100 citations

Life Sciences, Immunology, Pharmacology +16

Component‐resolved diagnosis of vespid venom‐allergic individuals: phospholipases and antigen 5s are necessary to identify <i><scp>V</scp>espula</i> or <i><scp>P</scp>olistes</i> sensitization

Rafaél I. Monsalve, Arantza Vega, L Marqués et al. · Allergy · 2012 · 88 citations · Full text

Life Sciences, Immunology, Allergy +16